Accessibility StatementSkip Navigation NEW YORK, Oct. 31, 2025 /PRNewswire/ -- Metsera, Inc. (NASDAQ: MTSR) ("Metsera" or the "Company") today issued the following statement in response to litigation filed against the Company by Pfizer: "Metsera disagrees with the allegations in Pfizer's complaint and will address them in the Delaware Court of Chancery." Disclosure Notice This release contains forward-looking information about, among other topics, Pfizer's proposed acquisition of Metsera, Pfizer's and Met ...

MEG Energy has delayed a shareholder vote on the proposed takeover of the company by sector player Cenovus, after a regulatory inquiry prompted the target company to provide additional information. Media quoting the chairman of MEG Energy’s board reported that the decision to postpone the vote was made with the knowledge of Cenovus and that the information requested by regulators concerned a transaction between Cenovus and its rival in the bidding for MEG Energy, Strathcona. The transaction, Reuters repo ...

PLANTATION, Fla.--(BUSINESS WIRE)--Chewy, Inc. (NYSE: CHWY) ("Chewy†), a leader in pet food, supplies and healthcare, announced today it has entered into a definitive agreement to acquire SmartPak Equine, LLC ("SmartEquine†) from Covetrus, Inc. SmartEquine, which rebranded from SmartPak in July 2025, is a leading U.S. provider of equine health products. The company is recognized for its proprietary subscription-based supplement programs, personalized nutrition plans, and broad portfolio of tack. ...

Accessibility StatementSkip Navigation Metsera Declares Novo Nordisk Proposal "Superior" Novo Nordisk Proposal Values Metsera at up to $77.75 per Share, a Total of Approximately $9 Billion Pursuant to Pfizer Merger Agreement, Metsera and Pfizer May Negotiate Potential Adjustments to Existing Transaction Pfizer Merger Agreement Remains in Effect; No Action Required by Metsera Shareholders At this time, the Pfizer Merger Agreement remains in full effect, and Metsera's Board of Directors reaffirm their recomme ...

Bagsværd, Denmark, 30 October 2025 – Novo Nordisk confirms that it submitted an unsolicited proposal to acquire Metsera, Inc. (Metsera). The acquisition of Metsera, including its early and development-stage incretin and non-incretin analogue peptide programmes, would provide Novo Nordisk the opportunity to maximise the potential of Metsera’s complementary portfolio and capabilities. An acquisition would be in line with Novo Nordisk’s long-term strategy of developing innovative and differentiated medicines a ...

DENVER--(BUSINESS WIRE)--BKV Corporation ("BKV†or the "Company†) (NYSE: BKV) and Banpu Power US Corporation ("BPPUS†) today announced that they have entered into a definitive purchase agreement (the "Purchase Agreement†) pursuant to which BKV will acquire from BPPUS one- half of BPPUS' interest in BKV-BPP Power, LLC ("BKV-BPP Power†or the "Power JV†) such that at the closing of the transaction, BKV would own 75% of the limited liability company interests in BKV- BPP Power. This transaction mark. ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Dive Brief: Thermo Fisher Scientific will acquire clinical trial data firm Clario Holdings for $8.9 billion in cash, the companies announced Wednesday. Clario is currently held by a shareholder group led by Astorg and Nordic Capital, Novo Holding and Cinven. In addition, Thermo has agreed to pay $125 million in January 2027, and up to $400 million in payments base ...

Thermo Fisher Scientific agreed to acquire endpoint data solutions provider Clario Holdings from a shareholder group for $8.88 billion in cash. ...

Huntington Bancshares has agreed to acquire Cadence Bank, a US bank with $53bn in assets, in a transaction valued at $7.4bn. Cadence Bank is headquartered in Houston, Texas and Tupelo, Mississippi. Under the terms of the agreement, Huntington will exchange 2.475 shares of its common stock for each Cadence share, based on a closing price of $16.07 on 24 October 2025. The acquisition is anticipated to be completed in the first quarter of 2026, subject to regulatory and shareholder approvals. Upon closing ...

收购交易核心信息 - HNI Corporation宣布达成最终协议 以现金加股票交易方式收购Steelcase Inc [1] - 收购交易完成条件包括获得HNI和Steelcase股东批准 反垄断批准及其他常规交割条件 [4] - 收购完成不取决于交换要约或同意征求的完成 也不受融资条件限制 [4] 交换要约与同意征求更新 - HNI将交换要约和同意征求的到期日从2025年10月27日下午5点延长至2025年12月5日下午5点 [2] - 在2025年10月9日的早期投标日期 HNI已获得足够同意以修订Steelcase契约 实现拟议修正案 [3] - 若收购预计无法在结算日前完成 HNI计划进一步延长交换要约的到期日 [5] 交换要约进展数据 - 针对Steelcase发行的2029年到期5.125%票据 总未偿本金金额为4.5亿美元 [8] - 截至2025年10月27日下午5点 已有效投标且未撤回的本金金额为3.50767亿美元 占总金额的77.95% [8] 公司业务概况 - HNI Corporation是一家工作场所家具和住宅建筑产品制造商 运营两个业务部门 [12] - 工作场所家具部门是全球领先的商业家具设计师和供应商 拥有多个独特品牌 [12] - 住宅建筑产品部门是美国领先的壁炉产品制造商和营销商 产品包括燃气 电力 木材和颗粒燃烧壁炉等 [12]